Gabify: Advancing Neurodevelopmental Care with AI Support

Gabify, a pioneering healthtech startup dedicated to neurodevelopmental care, has successfully secured $175,000 in a pre-seed funding round, primarily led by Inflection Point Ventures. The startup has also been awarded Rs 25 lakh from the Nidhi Seed Support Scheme through GHRTBI. This financial backing is earmarked for clinical validation, technology enhancement, and expanding the team. Gabify aims to broaden its outreach via B2B, B2C, and CSR-driven models, with a goal of positively impacting one million children by 2028.

Founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk, Gabify is developing an AI-enabled platform designed for the early screening and management of therapy related to speech and neurodevelopmental disorders such as autism and ADHD. The innovative platform harnesses a dual AI system that integrates voice and vision analysis to evaluate speech patterns, facial expressions, and behavioural signs in accordance with clinically validated metrics. It also adopts a human-in-the-loop strategy to ensure clinical validation.

Gabify has piloted its platform in over 35 preschools and daycare centres, and it is being utilised by a range of institutions including schools, hospitals, and clinics. Gabify has been recognised as one of the top 10 startups participating in DreamDeal, an initiative by Anupam Mittal, and is also engaged in Inflection Point Ventures’ IdeaSchool programme.